Biktarvy, formally known as bictegravir, includes a potent single-tablet therapy for controlling HIV infection. This medication unites three key antiviral agents: bictegravir, emtricitabine, and tenofovir alafenamide. It works by blocking the virus's ability to multiply within the body, significantly decreasing the viral burden. For many individu